🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 51654W101
- Market Cap
- Small Cap
- IPO
- 6/12/2020 · $15.00/share
Business: Lantern Pharma Inc. is a clinical stage biotechnology company focused on innovating the cancer drug development process by rescuing and repositioning drug candidates that others have tried, but failed, to develop and developing new drugs of its own using advanced genomics and artificial intelligence.
Company Contact
- CEO
- Panna Sharma
- CFO
- David R. Margrave
- Headquarters
- 1920 McKinney Avenue, 7th Floor, Dallas, TX 75201
- Phone
- 972-277-1136
- Investor Relations
- 972-277-1136 · info@lanternpharma.com